Agios Pharmaceuticals, Inc. (AGIO) |
| 28.2 0.4 (1.44%) 01-14 13:29 |
| Open: | 27.79 |
| High: | 28.4 |
| Low: | 27.52 |
| Volume: | 337,519 |
| Market Cap: | 1,644(M) |
| PE Ratio: | -4.02 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 35.09 |
| Resistance 1: | 30.04 |
| Pivot price: | 27.67 |
| Support 1: | 26.41 |
| Support 2: | 24.16 |
| 52w High: | 46 |
| 52w Low: | 22.24 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and AG-946 that is in Phase I clinical study for treating hemolytic anemias and other indications. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Financials
| EPS | -7.010 |
| Book Value | 22.040 |
| PEG Ratio | 0.00 |
| Gross Profit | -5.063 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -907.37 |
| Return on Assets (ttm) | -18.7 |
| Return on Equity (ttm) | -27.6 |
Company news
Tue, 13 Jan 2026
Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 29.77% Potential Upside in Biotechnology - DirectorsTalk Interviews
Mon, 12 Jan 2026
Agios Pharmaceuticals Outlines 2026 Strategic Priorities and Milestones - TradingView — Track All Markets
Mon, 12 Jan 2026
New anemia pill and sickle cell trials set up big year in rare disease care - Stock Titan
Thu, 08 Jan 2026
AGIO ALERT- Levi & Korsinsky Has Commenced an Investigation on Behalf of Agios Pharmaceuticals, Inc. Shareholders Who Lost Money - ACCESS Newswire
Thu, 08 Jan 2026
What Catalysts Are Rewriting The Story For Agios Pharmaceuticals (AGIO)? - Yahoo Finance
Tue, 06 Jan 2026
JP Morgan Raises Price Target for Agios Pharmaceuticals (AGIO) t - GuruFocus
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
